Non-specific microbial and inflammatory mediators

Non-specific microbial and inflammatory mediators is a broad descriptive category encompassing a diverse range of molecules that initiate, amplify, and regulate the host's inflammatory response. This group includes Pathogen-Associated Molecular Patterns (PAMPs), such as bacterial lipopolysaccharides or viral double-stranded RNA, which are recognized by the innate immune system as exogenous threats (Janeway, 1989). It also includes Damage-Associated Molecular Patterns (DAMPs), such as HMGB1 or heat shock proteins, which are endogenous molecules released during cellular stress or necrosis (Matzinger, 1994). These mediators interact with various pattern recognition receptors (PRRs) to trigger signaling pathways that result in the secretion of pro-inflammatory cytokines and chemokines (Nathan, 2002). While these mediators are essential for effective host defense and tissue repair, their chronic or systemic overproduction is a primary driver of diseases such as sepsis, rheumatoid arthritis, and atherosclerosis (Singer et al., 2016). Because this term refers to a functional grouping of heterogeneous substances rather than a single molecular entity, it is not classified as a specific therapeutic target in drug development databases. Instead, pharmacological intervention typically focuses on neutralizing specific individual mediators or blocking their respective receptors.

Other names

Pathogen-associated molecular patternsPAMPsDamage-associated molecular patternsDAMPsInflammatory mediatorsPro-inflammatory cytokinesMicrobial products

Drugs typically act by neutralizing specific individual mediators (e.g., monoclonal antibodies), blocking their cognate receptors (e.g., receptor antagonists), or inhibiting the downstream intracellular signaling pathways (e.g., kinase inhibitors) activated by these molecules.